The polypill: the solution for prevention of coronary heart disease?

Article Sidebar

PDF
Published: 2009-08-29

Main Article Content

Hendarto Natadidjaja
Department of Internal Medicine Medical Faculty, Trisakti University

Abstract

In Western countries, cardiovascular disease is the most common cause of death and it is expected that it will continue to be so in the near future.(1) If the resulting physical impairment and psychosocial disturbances are also taken into account, clearly this is a serious problem from the viewpoint of productivity, quality of life, as well as community health level. Therefore the institution of preventive measures is an important issue. Unfortunately, however, currently preventive measures that are effective, safe, and at the same time practical and economical, are almost nonexistent.

Article Details

Issue

Vol. 28 No. 2 (2009)

Section

Review Article

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

How to Cite

The polypill: the solution for prevention of coronary heart disease?. (2009). Universa Medicina, 28(2), i-ii. https://univmed.org/ejurnal/index.php/medicina/article/view/230

References

Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJ. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003:362:271-80.

Panchin N, Cambon JP, Hanama G, Kadri Z, Genes N, Cablanche JM, et al. USIC 2000 Investigators. Impact of combined secondary prevention therapy after acute myocardial infarction: data from a nationwide French registry. Am Heart J 2005;150:1147-53.

Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.

Sleight P, Pouleur H, Zannad F. Benefits, challenges, and registerability of the polypill. European Heart Journal 2006;27:1651–6.